- The US IPO market experienced a slower start to the fall season this week as major offerings faced last-minute postponements due to cautious market conditions.
- Bamboo Insurance Services and Amaero both delayed their public debuts, following a weak post-IPO performance by peer Orion180.
- ADARx Pharmaceuticals successfully priced its upsized IPO to raise 446 million US dollars, finishing the week up 14 %.